| A Thomas Collins, MD | |
|
1600 116th Ave Ne, Suite #302, Bellevue, WA 98004-3014 | |
| (425) 455-5440 | |
| (425) 455-1431 |
| Full Name | A Thomas Collins |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology |
| Location | 1600 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699784561 | NPI | - | NPPES |
| 1471200 | Medicaid | WA |
| Entity Name | Seattle Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003319500 PECOS PAC ID: 9032021050 Enrollment ID: O20031211000532 |
News Archive
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
A panel of five cerebrospinal fluid biomarkers may help doctors to accurately diagnose patients with various forms of dementia and parkinsonian disorders, research published in the Archives of Neurology suggests.
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
Increased orthopaedic surgical procedures and an ageing baby boomer generation have been boosting the demand for bone grafts. Even as new applications and innovative products create exciting growth opportunities, the key challenge for bone graft substitutes suppliers is to produce material with clinical efficacy equivalent to, or surpassing, existing alternatives.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| A Thomas Collins, MD 1600 116th Ave Ne, Suite #302, Bellevue, WA 98004-3014 Ph: (425) 455-5440 | A Thomas Collins, MD 1600 116th Ave Ne, Suite #302, Bellevue, WA 98004-3014 Ph: (425) 455-5440 |
News Archive
CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.
Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
A panel of five cerebrospinal fluid biomarkers may help doctors to accurately diagnose patients with various forms of dementia and parkinsonian disorders, research published in the Archives of Neurology suggests.
Researchers at Mayo Clinic Center for Individualized Medicine have discovered a potential cause and a promising new treatment for inflammatory myofibroblastic tumors, a rare soft tissue cancer that does not respond to radiation or chemotherapy.
Increased orthopaedic surgical procedures and an ageing baby boomer generation have been boosting the demand for bone grafts. Even as new applications and innovative products create exciting growth opportunities, the key challenge for bone graft substitutes suppliers is to produce material with clinical efficacy equivalent to, or surpassing, existing alternatives.
› Verified 8 days ago
Ted W Farrand, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-1331 | |
Dr. Ashok Shimoji-krishnan, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-3802 | |
Dr. Romelia Perez, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1611 116th Ave Ne, Suite 132, Bellevue, WA 98004 Phone: 206-795-9797 | |
Dr. Richard Cecil Geary Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1750 112th Ave Ne, B102, Bellevue, WA 98004 Phone: 425-688-5460 Fax: 425-739-4667 | |
Dr. Edward William Freedman, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1621 114th Ave Se, Suite 221, Bellevue, WA 98004 Phone: 425-455-9900 Fax: 425-688-9987 | |
Ms. Claire Pastor, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se Ste 100, Bellevue, WA 98004 Phone: 425-462-9511 Fax: 425-462-8894 | |
Dr. Megan Christine Riddle, MD PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1231 116th Ave Ne Ste 350, Bellevue, WA 98004 Phone: 425-454-1010 Fax: 425-880-5816 |